Corroborating these results, the overall increase in CD8+ T cells in tumours treated with IGF-blocking antibody was also observed in whole tumour digests using CyTOF mass cytometry (Supplementary Figures S1E, F). The gene discussed is IGF1; the disease is neoplasm.